Immune expression of E-cadherin and α, β and γ-catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas

International Braz J Urol

Volumn 38, Issue 4, 2012, Pages 466-473

  dos Reis, Sabrina Thalita ^a   Leite, Katia Ramos Moreira ^a   Neto, Alcides Mosconi ^a   Júnior, José Pontes ^a   Viana, Nayara Izabel ^a   Antunes, Alberto Azoubel ^a   Dall'Oglio, Marcos Francisco ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alpha catenin; Cadherins; Carcinoma, Transitional cell; Urinary tract

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CADHERIN; CATENIN; CELL ADHESION MOLECULE; PLAKOGLOBIN; TUMOR MARKER;

AGED; ARTICLE; CARCINOMA; CHEMISTRY; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SEX RATIO; TIME; TISSUE MICROARRAY; URETER TUMOR; URINARY TRACT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA CATENIN; BETA CATENIN; CADHERINS; CARCINOMA; CATENINS; CELL ADHESION MOLECULES; EPIDEMIOLOGIC METHODS; FEMALE; GAMMA CATENIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; SEX DISTRIBUTION; TIME FACTORS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URETERAL NEOPLASMS; URINARY TRACT;

EID: 84871415334     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382012000400005     Document Type: Article

References (27)

1. Munoz JJ, Ellison LM: Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000; 164: 1523-5.
2. Park S, Hong B, Kim CS, Ahn H: The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol. 2004; 171(2 Pt 1):621-5.
3. Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M, et al.: Behavior of urothelial carcinoma with respect to anatomical location. J Urol. 2007; 177: 1715-20.
4. Dalbagni G: Prognostication of upper tract urothelial carcinoma: what do we really need? Eur Urol. 2010; 57: 582-3; discussion 583-5.
5. Hashimoto H, Sue Y, Saga Y, Tokumitsu M, Yachiku S: Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter. Int J Urol. 2000; 7: 457-63.
6. Inoue K, Kamada M, Slaton JW, Fukata S, Yoshikawa C, Tamboli P, et al.: The prognostic value of angiogenesis and metastasisrelated genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Clin Cancer Res. 2002; 8: 1863-70.
7. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991; 251: 1451-5.
8. Näthke IS, Hinck LE, Nelson WJ: Epithelial cell adhesion and development of cell surface polarity: possible mechanisms for modulation of cadherin function, organization and distribution. J Cell Sci Suppl. 1993; 17: 139-45.
9. Ozawa M, Nuruki K, Toyoyama H, Ohi Y: Cloning of an alternative form of plakoglobin (gamma-catenin) lacking the fourth armadillo repeat. J Biochem. 1995; 118: 836-40.
10. Wakatsuki S, Watanabe R, Saito K, Saito T, Katagiri A, Sato S, Tomita Y: Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder. Cancer Lett. 1996; 103: 11-7.
11. Kashibuchi K, Tomita K, Schalken JA, Kume H, Takeuchi T, Kitamura T: The prognostic value of E-cadherin, alpha-, betaand gamma-catenin in bladder cancer patients who underwent radical cystectomy. Int J Urol. 2007; 14: 789-94.
12. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, et al.: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998; 4: 844-7.
13. Charalabopoulos K, Tsambals S, Syrigos K, Giannakopoulos C, Kalfakakou V, Kiortsis D, et al.: Correlation of E-cadherin expression with clinicopathological data in patients suffering from transitional cell carcinoma of the bladder. Exp. Oncol. 2003; 25: 180-5.
14. Koksal IT, Ates M, Danisman A, Sezer C, Ciftcioglu A, Karpuzoglu G, et al.: Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma. Pathol Oncol Res. 2006; 12: 13-9.
15. Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, et al.: Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res. 1996; 56: 4154-8.
16. Garcia del Muro X, Torregrosa A, Muñoz J, Castellsagué X, Condom E, Vigués F, et al.: Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer. Eur J Cancer. 2000; 36: 357-62.
17. Syrigos KN, Harrington K, Waxman J, Krausz T, Pignatelli M: Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer. J Urol. 1998; 160: 1889-93.
18. Velickovic LJ, Hattori T, Visnjic M, Dimov I, Stojanovic M, Stefanovic V: E-cadherin expression in upper urothelial carcinoma in Balkan Endemic Nephropathy and non-endemic regions. Pathol Res Pract. 2009; 205: 682-9.
19. Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, et al.: CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog. 2002; 34: 187-98.
20. Ke XS, Qu Y, Goldfinger N, Rostad K, Hovland R, Akslen LA, et al.: Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation. PLoS One. 2008; 3: e3368.
21. De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI: E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology. 1999; 53: 707-13.
22. Lim MG, Adsay NV, Grignon DJ, Osunkoya AO: E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma. Mod Pathol. 2011; 24: 241-7.
23. Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Pizá P: Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int. 2010; 106: 1319-23.
24. Orsola A, Cecchini L, Raventós CX, Trilla E, Planas J, Landolfi S, et al.: Risk factors for positive findings in patients with highgrade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR. BJU Int. 2010; 105: 202-7.
25. Clairotte A, Lascombe I, Fauconnet S, Mauny F, Félix S, Algros MP, et al.: Expression of E-cadherin and alpha-, beta-, gamma- catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors. Am J Clin Pathol. 2006; 125: 119-26.
26. Gudjónsson S, Bendahl PO, Chebil G, Höglund M, Lindgren D, Lundberg LM, et al.: Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer? Scand J Urol Nephrol. 2011; 45: 270-7.
27. Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, et al.: Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol. 2005; 48: 764-70.